QOP
VIR icon

Quinn Opportunity Partners’s Vir Biotechnology VIR Stock Holding History

Quinn Opportunity Partners’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$723K Hold
70,976
– – 0.03% 243
2026
Q1 		$636K Buy
70,976
+20,000
+39% +$159K 0.03% 249
2025
Q4 		$307K Hold
50,976
– – 0.01% 314
2025
Q3 		$291K Hold
50,976
– – 0.02% 270
2025
Q2 		$257K Hold
50,976
– – 0.02% 286
2025
Q1 		$330K Sell
50,976
-15,000
-23% -$133K 0.02% 303
2024
Q4 		$484K Buy
+65,976
New +$520K 0.03% 265

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Quinn Opportunity Partners's VIR Position: Q2 2026 in Review

Quinn Opportunity Partners held its Vir Biotechnology (VIR) position steady in Q2 2026 at 70,976 shares worth $723K. The position accounts for 0.03% of the portfolio, ranked #243.

Quinn Opportunity Partners first reported a position in VIR in Q4 2024 and has held it in 7 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Quinn Opportunity Partners held 70,976 shares of Vir Biotechnology worth $723K as of Q2 2026.
  • Quinn Opportunity Partners left its Vir Biotechnology share count unchanged in Q2 2026.
  • Vir Biotechnology made up 0.03% of Quinn Opportunity Partners's portfolio in Q2 2026, its #243 holding.
  • Quinn Opportunity Partners first reported a position in Vir Biotechnology in Q4 2024 and has held it in 7 quarters since.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Quinn Opportunity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.